5-HT1A/1B receptors as targets for optimizing pigmentary responses in C57BL/6 mouse skin to stress

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Wu, Hua Li ^a   Pang, Si Lin ^a   Liu, Qiong Zhen ^a   Wang, Qian ^a   Cai, Min Xuan ^a   Shang, Jing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOPACHROME TAUTOMERASE; MONOPHENOL MONOOXYGENASE; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; TYROSINASE RELATED PROTEIN 1;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DEPIGMENTATION; DOWN REGULATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HAIR FOLLICLE; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MALE; MELANOCYTE; MELANOGENESIS; MELANOMA CELL; MICROSCOPY; MORPHOLOGY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTONINERGIC SYSTEM; SKIN; SKIN PIGMENTATION; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

ANIMALS; CELL LINE, TUMOR; HAIR COLOR; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MELANINS; MELANOCYTES; MELANOMA, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; OXIDOREDUCTASES; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; SKIN; SKIN PIGMENTATION; STRESS, PSYCHOLOGICAL;

EID: 84896762804     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089663     Document Type: Article

References (75)

1. Slominski AT, Zmijewski MA, Zbytek B, Tobin DJ, Theoharides TC, et al. (2013) Key Role of CRF in the Skin Stress Response System. Endocr Rev 34: 827-884.
2. Zmijewski MA, Slominski AT (2011) Neuroendocrinology of the skin: An overview and selective analysis. Dermatoendocrinol 3: 3-10.
3. Slominski A, Wortsman J (2000) Neuroendocrinology of the skin. Endocr Rev 21: 457-487.
4. Schallreuter KU, Lemke KR, Pittelkow MR, Wood JM, Korner C, et al. (1995) Catecholamines in human keratinocyte differentiation. J Invest Dermatol 104: 953-957.
5. Slominski A, Paus R, Schadendorf D (1993) Melanocytes as "sensory" and regulatory cells in the epidermis. J Theor Biol 164: 103-120.
6. Arck PC, Slominski A, Theoharides TC, Peters EM, Paus R (2006) Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 126: 1697-1704. (Pubitemid 44086503)
7. Slominski A (2009) Neuroendocrine activity of the melanocyte. Exp Dermatol 18: 760-763.
8. Slominski AT, Zmijewski MA, Skobowiat C, Zbytek B, Slominski RM, et al. (2012) Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol 212: 1-115.
9. Paus R, Cotsarelis G (1999) The biology of hair follicles. N Engl J Med 341: 491-497. (Pubitemid 29372890)
10. Krause K, Foitzik K (2006) Biology of the hair follicle: the basics. Semin Cutan Med Surg 25: 2-10.
11. Muller-Rover S, Handjiski B, van der Veen C, Eichmuller S, Foitzik K, et al. (2001) A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 117: 3-15. (Pubitemid 32652434)
12. Arck PC, Handjiski B, Peters EM, Peter AS, Hagen E, et al. (2003) Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol 162: 803-814. (Pubitemid 36237489)
13. Aoki E, Shibasaki T, Kawana S (2003) Intermittent foot shock stress prolongs the telogen stage in the hair cycle of mice. Exp Dermatol 12: 371-377. (Pubitemid 36992410)
14. Katayama M, Aoki E, Suzuki H, Kawana S (2007) Foot shock stress prolongs the telogen stage of the spontaneous hair cycle in a non-depilated mouse model. Exp Dermatol 16: 553-560. (Pubitemid 46958560)
15. Leonard BE, Myint A (2009) The psychoneuroimmunology of depression. Hum Psychopharmacol 24: 165-175.
16. Chaouloff F (1993) Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Brain Res Rev 18: 1-32.
17. Dinan TG (1996) Serotonin: current understanding and the way forward. Int Clin Psychopharmacol 1: 19-21.
18. Azmitia EC (2007) Serotonin and brain: evolution, neuroplasticity, and homeostasis. Int Rev Neurobiol 77: 31-56.
19. Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71: 533-554. (Pubitemid 34219205)
20. Lanfumey L, Pardon MC, Laaris N, Joubert C, Hanoun N, et al. (1999) 5-HT1A autoreceptor desensitization by chronic ultramild stress in mice. Neuroreport 10: 3369-3374.
21. Wang SH, Zhang ZJ, Guo YJ, Teng GJ, Chen BA (2009) Decreased expression of serotonin 1A receptor in the dentate gyrus in association with chronic mild stress: a rat model of post-stroke depression. Psychiatry Res 170: 245-251.
22. Ossowska G, Nowa G, Kata R, Klenk-Majewska B, Danilczuk Z, et al. (2001) Brain monoamine receptors in a chronic unpredictable stress model in rats. J Neural Transm 108: 311-319. (Pubitemid 32703905)
23. Slominski A, Wortsman J, Tobin DJ (2005) The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J 19: 176-194. (Pubitemid 40189259)
24. Slominski A, Pisarchik A, Johansson O, Jing C, Semak I, et al. (2003) Tryptophan hydroxylase expression in human skin cells. Biochim Biophys Acta 1639: 80-86. (Pubitemid 38366211)
25. Kushnir-Sukhov NM, Brown JM, Wu Y, Kirshenbaum A, Metcalfe DD (2007) Human mast cells are capable of serotonin synthesis and release. J Allergy Clin Immunol 119: 498-499. (Pubitemid 46204791)
26. Slominski A, Pisarchik A, Semak I, Sweatman T, Wortsman J, et al. (2002) Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 16: 896-898.
27. Nordlind K, Azmitia EC, Slominski A (2008) The skin as a mirror of the soul: exploring the possible roles of serotonin. Exp Dermatol 17: 301-311. (Pubitemid 351338673)
28. Slominski A, Tobin DJ, Shibahara S, Wortsman J (2004) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84: 1155-1228. (Pubitemid 39287950)
29. Slominski A, Pisarchik A, Zbytek B, Tobin DJ, Kauser S, et al. (2003) Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol 196: 144-153. (Pubitemid 36676452)
30. Levitin HP (1980) Further evidence that serotonin may be a physiological melanocyte-stimulating hormone-releasing factor in the lizard Anolis carolinensis. Gen Comp Endocrinol 40: 8-14.
31. Lee HJ, Park MK, Kim SY, Park Choo HY, Lee AY, et al. (2011) Serotonin induces melanogenesis via serotonin receptor 2A. Br J Dermatol 165: 1344-1348.
32. Liao S, Shang J, Tian X, Fan X, Shi X, et al. (2012) Up-regulation of melanin synthesis by the antidepressant fluoxetine. Exp Dermatol 21: 635-637.
33. Ameisen JC, Meade R, Askenase PW (1989) A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells. J Immunol 142: 3171-3179. (Pubitemid 19129939)
34. Hashizume H, Takigawa M (2006) Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 6: 335-339. (Pubitemid 44368239)
35. Kurbanov Kh, Berezov TT (1976) [Tryptophan metabolism in vitiligo]. Vopr Med Khim 22: 683-687.
36. Chase HB (1954) Growth of the hair. Physiol Rev 34: 113-126.
37. Slominski A, Paus R, Costantino R (1991) Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J Invest Dermatol 96: 172-179.
38. Yin D, Tuthill D, Mufson RA, Shi Y (2000) Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J Exp Med 191: 1423-1428. (Pubitemid 30227128)
39. Gamaro GD, Prediger ME, Lopes J, Bassani MG, Dalmaz C (2008) Fluoxetine alters feeding behavior and leptin levels in chronically-stressed rats. Pharmacol Biochem Behav 90: 312-317.
40. Ciribassi J, Luescher A, Pasloske KS, Robertson-Plouch C, Zimmerman A, et al. (2003) Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats. Am J Vet Res 64: 994-998. (Pubitemid 36958221)
41. Parikh DK, Ghosh TK (2005) Feasibility of transdermal delivery of fluoxetine. AAPS PharmSciTech 6: E144-149. (Pubitemid 41631759)
42. Jung E, Kang YP, Yoon IS, Kim JS, Kwon SW, et al. (2013) Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation. Int J Pharm 456: 362-369.
43. Yamada J, Sugimoto Y, Ujikawa M (1999) The serotonin precursor 5-hydroxytryptophan elevates serum leptin levels in mice. Eur J Pharmacol 383: 49-51. (Pubitemid 29509821)
44. Khatri N, Simpson KL, Lin RC, Paul IA (2013) Lasting neurobehavioral abnormalities in rats after neonatal activation of serotonin 1A and 1B receptors: possible mechanisms for serotonin dysfunction in autistic spectrum disorders. Psychopharmacology (Berl) 24: 24.
45. Lockridge A, Newland B, Printen S, Romero GE, Yuan LL (2013) Head movement: a novel serotonin-sensitive behavioral endpoint for tail suspension test analysis. Behav Brain Res 246: 168-178.
46. Hosoda H, Doi K, Nagaya N, Okumura H, Nakagawa E, et al. (2004) Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clin Chem 50: 1077-1080. (Pubitemid 38725803)
47. Papageorgiou A, Denef C (2007) Stimulation of growth hormone release by 5-hydroxytryptamine (5-HT) in cultured rat anterior pituitary cell aggregates: evidence for mediation by 5-HT2B, 5-HT7, 5-HT1B, and ketanserin-sensitive receptors. Endocrinology 148: 4509-4522. (Pubitemid 47295695)
48. Lee J, Wu W, Kopan R (2008) Murine vibrissae cultured in serum-free medium reinitiate anagen. J Invest Dermatol 128: 482-485.
49. Leon-Ponte M, Ahern GP, O'Connell PJ (2007) Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 109: 3139-3146. (Pubitemid 46572497)
50. Zhou J, Shang J, Song J, Ping F (2013) Interleukin-18 augments growth ability of primary human melanocytes by PTEN inactivation through the AKT/NF-kappaB pathway. Int J Biochem Cell Biol 45: 308-316.
51. Jones K, Hughes J, Hong M, Jia Q, Orndorff S (2002) Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. Pigment Cell Res 15: 335-340.
52. Tomita Y, Maeda K, Tagami H (1992) Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res 5: 357-361.
53. Widlund HR, Fisher DE (2003) Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene 22: 3035-3041. (Pubitemid 36713753)
54. Kot M, Pilc A, Daniel WA (2012) Simultaneous alterations of brain and plasma serotonin concentrations and liver cytochrome P450 in rats fed on a tryptophan-free diet. Pharmacol Res 66: 292-299.
55. Fadda F (2000) Tryptophan-Free Diets: A Physiological Tool to Study Brain Serotonin Function. News Physiol Sci 15: 260-264.
56. Inoue K, Hosoi J, Ideta R, Ohta N, Ifuku O, et al. (2003) Stress augmented ultraviolet-irradiation-induced pigmentation. J Invest Dermatol 121: 165-171. (Pubitemid 36900468)
57. Azmitia EC Jr, McEwen BS (1969) Corticosterone regulation of tryptophan hydroxylase in midbrain of the rat. Science 166: 1274-1276.
58. Abumaria N, Rygula R, Havemann-Reinecke U, Ruther E, Bodemer W, et al. (2006) Identification of genes regulated by chronic social stress in the rat dorsal raphe nucleus. Cell Mol Neurobiol 26: 145-162. (Pubitemid 43881821)
59. Ali SA, Salim S, Sahni T, Peter J, Ali AS (2012) 5-HT receptors as novel targets for optimizing pigmentary responses in dorsal skin melanophores of frog, Hoplobatrachus tigerinus. Br J Pharmacol 165: 1515-1525.
60. Ou XM, Storring JM, Kushwaha N, Albert PR (2001) Heterodimerization of mineralocorticoid and glucocorticoid receptors at a novel negative response element of the 5-HT1A receptor gene. J Biol Chem 276: 14299-14307.
61. Huang J, Azmitia EC (1999) Homologous regulation of 5-HT1A receptor mRNA in adult rat hippocampal dentate gyrus. Neurosci Lett 270: 5-8. (Pubitemid 29322984)
62. Aioi A, Okuda M, Matsui M, Tonogaito H, Hamada K (2001) Effect of high population density environment on skin barrier function in mice. J Dermatol Sci 25: 189-197. (Pubitemid 32184506)
63. Lundeberg L, El-Nour H, Mohabbati S, Morales M, Azmitia E, et al. (2002) Expression of serotonin receptors in allergic contact eczematous human skin. Arch Dermatol Res 294: 393-398. (Pubitemid 35435746)
64. Boyer EW, Shannon M (2005) The serotonin syndrome. N Engl J Med 352: 1112-1120.
65. Schallreuter KU, Salem MA, Gibbons NC, Martinez A, Slominski R, et al. (2012) Blunted epidermal L-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 1: Epidermal H2O2/ONOO(-)-mediated stress abrogates tryptophan hydroxylase and dopa decarboxylase activities, leading to low serotonin and melatonin levels. FASEB J 26: 2457-2470.
66. Liu N, Wang LH, Guo LL, Wang GQ, Zhou XP, et al. (2013) Chronic restraint stress inhibits hair growth via substance P mediated by reactive oxygen species in mice. PLoS One 8: e61574.
67. Flores CM, Hernandez MC, Hargreaves KM, Bayer BM (1990) Restraint stress-induced elevations in plasma corticosterone and beta-endorphin are not accompanied by alterations in immune function. J Neuroimmunol 28: 219-225. (Pubitemid 20207817)
68. Noh SJ, Kang DW, Yoo SB, Lee JY, Kim JY, et al. (2012) Stress-responsive hypothalamic-nucleus accumbens regulation may vary depending on stressors. Indian J Exp Biol 50: 447-454.
69. Baumann MH, Williams Z, Zolkowska D, Rothman RB (2011) Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat. Drug Alcohol Depend 114: 147-152.
70. Kaneko M, Kumashiro H, Takahashi Y, Hoshino Y (1979) L-5HTP treatment and serum 5-HT level after L-5-HTP loading on depressed patients. Neuropsychobiology 5: 232-240. (Pubitemid 9178198)
71. Stenfors C, Ross SB (2002) Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine. Life Sci 71: 2867-2880.
72. Dawood S, Bano S (2005) Brain tryptophan metabolism remained unaltered in restraint stressed rats following fluoxetine administration. Pak J Pharm Sci 18: 49-54.
73. Pinna G, Costa E, Guidotti A (2006) Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology (Berl) 186: 362-372. (Pubitemid 43800838)
74. Semont A, Fache M, Hery F, Faudon M, Youssouf F, et al. (2000) Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-L-tryptophan or fluoxetine. J Neuroendocrinol 12: 736-744. (Pubitemid 30497100)
75. Grignaschi G, Mantelli B, Samanin R (1993) The hypophagic effect of restraint stress in rats can be mediated by 5-HT2 receptors in the paraventricular nucleus of the hypothalamus. Neurosci Lett 152: 103-106. (Pubitemid 23149324)